Epic Bio Presents New Data on Epigenetic Editing Platform at CRISPR Frontiers Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today presented new data on its epigenetic editing platform at Cold Spring Harbor Laboratory’s Genome Engineering: CRISPR Frontiers conference, being held August 16-20, 2023, in Cold Spring Harbor, NY. Epic’s six poster presentations detail a variety of discoveries that expand upon the capabilities of the company’s powerful Ge